153 related articles for article (PubMed ID: 31218593)
1. An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms.
Cracolici V; Parilla M; Henriksen KJ; Cipriani NA
Head Neck Pathol; 2020 Jun; 14(2):399-405. PubMed ID: 31218593
[TBL] [Abstract][Full Text] [Related]
2. Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.
Cracolici V; Ritterhouse LL; Segal JP; Puranik R; Wanjari P; Kadri S; Parilla M; Cipriani NA
Am J Surg Pathol; 2020 Jul; 44(7):881-892. PubMed ID: 32282345
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin (NGAL) immunohistochemical expression in follicular cell-derived thyroid tumors: a novel diagnostic tool?
Barresi V; Leni A; Tuccari G; Barresi G
Histol Histopathol; 2012 Mar; 27(3):329-36. PubMed ID: 22237710
[TBL] [Abstract][Full Text] [Related]
4. Is atypical follicular adenoma of the thyroid a preinvasive malignancy?
Tzen CY; Huang YW; Fu YS
Hum Pathol; 2003 Jul; 34(7):666-9. PubMed ID: 12874762
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].
Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A
Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830
[TBL] [Abstract][Full Text] [Related]
6. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
9. Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy.
Heikkilä A; Siironen P; Hagström J; Heiskanen I; Sankila R; Louhimo J; Haglund C; Arola J
APMIS; 2010 Nov; 118(11):846-54. PubMed ID: 20955457
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
13. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation.
Mete O; Asa SL
Mod Pathol; 2011 Dec; 24(12):1545-52. PubMed ID: 21804527
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.
Williams MD; Zhang L; Elliott DD; Perrier ND; Lozano G; Clayman GL; El-Naggar AK
Hum Pathol; 2011 Sep; 42(9):1213-20. PubMed ID: 21420716
[TBL] [Abstract][Full Text] [Related]
15. The value of histomorphometric nuclear parameters in the diagnosis of well differentiated follicular carcinomas and follicular adenomas of the thyroid gland.
Eldar S; Sabo E; Cohen A; Misselevich I; Abrahamson J; Cohen O; Kelner J; Boss JH
Histopathology; 1999 May; 34(5):453-61. PubMed ID: 10231421
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas.
Oyama T; Vickery AL; Preffer FI; Colvin RB
Hum Pathol; 1994 Mar; 25(3):271-5. PubMed ID: 8150457
[TBL] [Abstract][Full Text] [Related]
17. Value of immunohistochemical expression of p27 and galectin-3 in differentiation between follicular adenoma and follicular carcinoma.
Abulkheir IL; Mohammad DB
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):131-40. PubMed ID: 22553813
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract][Full Text] [Related]
19. Late bone metastasis from an encapsulated follicular carcinoma of the thyroid without capsular and vascular invasion.
Mizukami Y; Nonomura A; Hayashi Y; Ohmura K; Michigishi T; Noguchi M; Nakamura S; Ishizaki T
Pathol Int; 1996 Jun; 46(6):457-61. PubMed ID: 8869998
[TBL] [Abstract][Full Text] [Related]
20. CD56 expression in benign and malignant thyroid lesions.
Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
